Nucleotide analog RNA polymerase inhibitor

This page covers all Nucleotide analog RNA polymerase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting SARS-CoV-2 RNA polymerase.

Targets

SARS-CoV-2 RNA polymerase

Marketed (2)

• Veklury · Gilead Sciences · Metabolic · 2200
  Remdesivir is an antiviral nucleotide analog RNA polymerase inhibitor with activity against SARS-CoV-2.
• REMDESIVIR

Patent intelligence

• nucleotide analog rna polymerase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates